ArticleMolecular therapy. Oncology2026

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Gabriella Antignani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.